Bills of Congress by U.S. Congress

National Biotechnology Safety Act

Summary

The National Biotechnology Safety Act authorizes the National Science Foundation (NSF) to conduct research for biotechnology risk assessment. It directs the NSF to establish a program within the Directorate for Technology, Innovation, and Partnerships to fund research concerning the environmental introduction of organisms produced with biotechnology. The act also mandates a two-phase study by the National Academies of Science, Engineering, and Medicine on the safety and benefits of biotechnology.

Expected Effects

This act aims to enhance the understanding and regulation of biotechnology products. It will likely lead to increased research funding for biotechnology risk assessment. The National Academies' study could influence future regulations and public perception of biotechnology.

Potential Benefits

  • Enhanced understanding of potential risks and benefits of biotechnology.
  • Development of clear regulatory pathways for biotechnology products.
  • Support for innovation and commercialization in the biotechnology sector.
  • Improved public safety through better risk assessment and management.
  • Potential for advancements in agriculture, medicine, industry, and defense.

Potential Disadvantages

  • Potential for increased regulatory burden on biotechnology companies.
  • Risk of research findings leading to overly cautious regulations that stifle innovation.
  • Possible delays in the commercialization of beneficial biotechnology products.
  • Concerns about the ethical, legal, and social implications of biotechnology research.
  • Potential for misuse of research findings to create unnecessary public fear.

Constitutional Alignment

The act aligns with the Constitution's general welfare clause (Preamble) by promoting research that could lead to safer and more beneficial biotechnology products. Congress's power to regulate commerce (Article I, Section 8) provides a basis for regulating biotechnology products that enter the market. The act does not appear to infringe on any specific constitutional rights or limitations.

Impact Assessment: Things You Care About

This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).